ПРОИЗВОДНЫЕ ДИФЕНИЛАЗЕТИДИНОНА ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ МЕТАБОЛИЗМА ЛИПИДОВ

摘要

Compounds of formula (I): (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described